ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Exicure Inc

Exicure Inc (XCUR)

0.541
0.0968
(21.79%)
Closed June 03 4:00PM
0.50
-0.041
( -7.58% )
Pre Market: 7:47AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.50
Bid
0.4896
Ask
0.50
Volume
22,242
0.00 Day's Range 0.00
0.30 52 Week Range 1.50
Market Cap
Previous Close
0.541
Open
-
Last Trade Time
07:45:51
Financial Volume
-
VWAP
-
Average Volume (3m)
292,237
Shares Outstanding
8,648,307
Dividend Yield
-
PE Ratio
-1.81
Earnings Per Share (EPS)
-0.3
Revenue
28.83M
Net Profit
-2.58M

About Exicure Inc

Exicure Inc is a clinical-stage biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA ... Exicure Inc is a clinical-stage biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Exicure Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker XCUR. The last closing price for Exicure was $0.54. Over the last year, Exicure shares have traded in a share price range of $ 0.30 to $ 1.50.

Exicure currently has 8,648,307 shares outstanding. The market capitalization of Exicure is $4.67 million. Exicure has a price to earnings ratio (PE ratio) of -1.81.

XCUR Latest News

Exicure, Inc. Received Nasdaq Notice of a Delisting Determination

Exicure, Inc. (β€œExicure” or the β€œCompany”) (Nasdaq: XCUR), announced today it received notice of a delisting determination (the β€œStaff Delisting Determination”) from the Listing Qualifications...

Exicure, Inc. Reports Third Quarter 2023 Financial Results

Exicure, Inc. (Nasdaq: XCUR), has historically been an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. In...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.03728.038029386340.46280.85490.315130640350.46659099CS
4-0.012-2.343750.5120.85490.38273320.46543266CS
12-0.186-27.11370262390.6860.85490.32922370.47567781CS
260.024.166666666670.480.860.36388250.57327338CS
52-0.3583-41.74531049750.85831.50.33321940.5902896CS
156-1.2-70.58823529411.73.240.084626394620.36478176CS
260-1.7-77.27272727272.23.840.084617551780.51632946CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MLGOMicroAlgo Inc
$ 4.07
(160.90%)
13.34M
FRESFresh2 Group Ltd
$ 0.515
(45.07%)
5.47M
CORZCore Scientific Inc
$ 6.78
(39.22%)
6.35M
ANNXAnnexon Inc
$ 5.67
(23.80%)
3.55M
ESGLESGL Holdings Ltd
$ 1.15
(21.05%)
113
BWAQBlue World Acquisition Corporation
$ 8.00
(-26.67%)
3
ALBTAvalon GloboCare Corporation
$ 0.91
(-26.02%)
871.44k
SCKTSocket Mobile Inc
$ 1.00
(-18.03%)
1
BCGBinah Capital Group Inc
$ 9.51
(-17.02%)
8.08k
ABLVAble View Global Inc
$ 0.9001
(-16.66%)
96
MLGOMicroAlgo Inc
$ 4.07
(160.90%)
13.34M
CORZCore Scientific Inc
$ 6.78
(39.22%)
6.35M
PEGYPineapple Energy Inc
$ 0.2349
(20.28%)
6.29M
LUXHLuxUrban Hotels Inc
$ 0.3262
(5.91%)
5.71M
FRESFresh2 Group Ltd
$ 0.515
(45.07%)
5.47M

XCUR Discussion

View Posts
boston127 boston127 17 hours ago
Thank you. I'm going to stay on

the sidelines with this. Slipping into the OTC is not what I was looking for. Thanks again.
πŸ‘οΈ0
LocWolf LocWolf 18 hours ago
You can access the company but since they haven't updated security certificates you just need to enter the company from previous links you might access over the internet. As for XCUR? it seems on June 13th if the company does not get a blessing to extend platform this will fall back into the OTC market place. I'm not even going to check to see why the massive share traded last week but believe that was all about raising money however? I'm shaking my head as the leading investment corporate entity in S. Korea has plenty of dollars so my guess is either they didn't fully understand messing with XCUR, A deal collapse or the South Korean entity is still not ready to jump into this public USA trading just yet.

* just push through the expired cert and you will see you can still access the site.
πŸ‘οΈ0
boston127 boston127 2 days ago
Error message trying to view XCUR's website.

I get a warning message from Google when I click on it. Anyone else have that problem?
πŸ‘οΈ0
LocWolf LocWolf 7 days ago
I figure .20 will be my entry again.
πŸ‘οΈ0
Invest-in-America Invest-in-America 7 days ago
And @VHAI is noted, Sir --- THANKS!!
πŸ‘οΈ0
TIMGZ TIMGZ 7 days ago
SOUNDS GOOD, THANKS********CHECK OUT VHAI****IPOed in JAN FEB***INSIDER BOUGHT AT $4 SOME CHANGE.
πŸ‘οΈ0
Invest-in-America Invest-in-America 7 days ago
XCUR: Hey, Capt. TIM!! (As I said to 'FinalCD' earlier this moring, it's a real puzzle here for any kind of price increase. But ain't that the same for so many other soaring stocks?? Heck, what's behind the @STSS monster run --- and the only 'news' they had was a 'hold-to-sell' rating by some Wall Street guru. Nevertheless, if you are still pondering an XCUR grab, then be sure to WAIT until at least 11:00 a.m. NEW YORK time before you jump.)


"Howdy, Captain TIM!! I hope you had a great MAMMARY DAY weekend, Homeboy!!"
//////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////
πŸ‘οΈ0
TIMGZ TIMGZ 7 days ago
SO BUY XCUR OR DON'T BUY XCUR***** WHAT IS YOUR TAKE ON THIS MY FRIEND
πŸ‘οΈ0
Invest-in-America Invest-in-America 7 days ago
XCUR: Strange indeed; since had a 5-23-24 NASDAQ "Delisting" warning, & a ZERO revs. & other bad financials shortly before the "Delisting" routine. (But then, aren't DELISTING & LOW PRICE warnings 'trending' of late for a nice big soaring PRICE????)
πŸ‘οΈ0
TheFinalCD TheFinalCD 7 days ago
XCUR WHY IS THIS TURD MOVING

OH I FORGOT IT DOESNT NEED A VALID REASON IN 2024

SMH
πŸ‘οΈ0
LocWolf LocWolf 2 months ago
WELL? will XCUR become a company that deals with super large 3D advertising digital screens? (you will not need 3D glasses with this technology) or how about becoming a USA distribution hub either involving manufacturing or even if the hub might be just for marketing South Korea's 3D products? Something needs to give way soon.
πŸ‘οΈ0
LocWolf LocWolf 4 months ago
Like I said XCUR isn't Exicure anymore and with us not actually doing any real development plus of course these guys haven't a clue, at the value of those patents. The players/institutional investments will be playing in Bluejay however you might hope that Bluejay might reverse merger but believe that won't happen.
πŸ‘οΈ0
LocWolf LocWolf 4 months ago
One reason we won't see what we want in share price is because Exicure isn't Exicure any more. Sure our past management screwed us but these new kids on the block, from Korea had no clue about doing anything within the develop anything meaning their interest (seemed) to be more on having a public trading entity. Proof of the pudding is that they had no idea about the contract development between Exicure and NWU.

We lost massively in all out institutional investments and now are struggling to stay in the NASDAQ household in-which in several more months we most likely will kiss the OTC.

We are just a company trying to give out our valuable patents but just read the latest press release they haven't a clue of the value nor the work that went into all this in past years. So all we will get is crumbs. Now even the company we just made the tiny deal with will be at least 2 - 3 years in developing the studies, mixes and potential pre clinical.

In other words for us who stay for then RS may not but hop and poke with time. As for the traders timing might be bad.

Now the S Korean big dog - money man is successful but I'm not sure about the guy's presently holding offices. Is it possible the company will be more of a business hub between the US and SK?
πŸ‘οΈ0
Invest-in-America Invest-in-America 4 months ago
XCUR: Suddenly appearing upon, and movin' UP, this list --- out of nowhere!!
https://www.barchart.com/investing-ideas/penny-stocks?orderBy=percentChange5d&orderDir=desc
πŸ‘οΈ0
Invest-in-America Invest-in-America 4 months ago
XCUR: Suddenly appearing upon, and movin' UP, this list --- out of nowhere!!
https://www.barchart.com/investing-ideas/penny-stocks?orderBy=percentChange5d&orderDir=desc
πŸ‘οΈ0
Invest-in-America Invest-in-America 4 months ago
XCUR: Here we Gooooooooooo!!! (Maybe there IS a God!!!!) Don't like my Atheistic jokes, then SCREW-YAH!!! Face MECCA, or put your hands on your "WAILING BUTTS"!!!)
πŸ‘οΈ0
BurgerKing82 BurgerKing82 4 months ago
If it breaks .80 again...it may grow legs...under 9 million OS?
πŸ‘οΈ0
TheFinalCD TheFinalCD 4 months ago
Thanks the robots gapped it up too high too quick, so didnt have a big trading range

whats your thoughts on the action and the XCUR news
πŸ‘οΈ0
LocWolf LocWolf 4 months ago
The system can design drug plan(s) digitally and pursue 3 different tasks at the same time, also turning on and off cells and delivering by way of scavenger receptors, delivering less drug, raising efficiency and causing less damage to the liver/patients.
πŸ‘οΈ0
LocWolf LocWolf 4 months ago
No doubt we needed something but weak statements that lack real information...it appears this effort might be to hold/move share price that may very well work against the company. Being invested in Exicure for around 4 years it appears the other company was in great need of a new way/delivery system plus the 3D digital system which was why I invested in XCUR years ago.
πŸ‘οΈ0
BurgerKing82 BurgerKing82 4 months ago
Is it worth buying now?...or wait?
πŸ‘οΈ0
subslover subslover 4 months ago
Exicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of Hepatitis
CHICAGO--(BUSINESS WIRE)-- Exicure, Inc., (NASDAQ:XCUR) a company that historically developed nucleic acid therapies, and Bluejay Therapeutics, Inc., a private clinical stage biopharmaceutical company focused on viral and liver diseases, announced today that Bluejay Therapeutics, Inc. ("Bluejay") and Exicure, Inc. ("Exicure") entered into a patent license agreement to develop cavrotolimod for potential treatment for hepatitis.

Under the terms of the agreement, Bluejay will receive an exclusive license in the field of hepatitis to all of Exicure’s relevant patents. Bluejay paid Exicure an initial small, one-time payment after the execution of this Agreement. Exicure will also be entitled to modest royalties on future net sales on all licensed technology by Bluejay during the term of the licensed patents. Exicure will be responsible for, and make all decisions concerning, the preparation, filing, prosecution, and maintenance for each patent and patent application included within the licensed patents.

"Our partnership with Bluejay continues the development of cavrotolimod," said Paul Kang, Chief Executive Officer of Exicure. "Exicure has spent considerable resources to discover and develop cavrotolimod. While historically, we focused on oncology, Bluejay’s commitment and expertise in developing cavrotolimod for potential treatment of hepatitis makes them an ideal partner to expand the use case of cavrotolimod," added Mr. Kang.

About Exicure

Exicure, Inc. has historically been an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. Following its recent restructuring and suspension of clinical and development activities, the Company is exploring strategic alternatives to maximize stockholder value, both with respect to its historical biotechnology assets and more broadly. For further information, see www.exicuretx.com.

Forward-Looking Statements
πŸ‘οΈ0
Invest-in-America Invest-in-America 4 months ago
XCUR: News launched exactly ONE MINUTE after the Close!! (HAH!!! Is this a 'SYSTEM' of some sort??? To EXPLOIT the Post-M??? Inquiring minds need to know!!!)


When we got married!!!


On our Honeymoon!!!
πŸ‘οΈ0
Awl416 Awl416 4 months ago
Exicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of Hepatitis
πŸ‘οΈ0
LocWolf LocWolf 4 months ago
Paul Kang will reverse a private company into XCUR but in the meantime he has paid directors the typical $20k so that he can maintain listing and also push the the SEC tolerances to the limit before actually being delisted. I believe we will not be involved in any of the past operations that we were and I believe from all the reading I have done. I keep shaking my head on what business we will do and feel that Mr. Kang is using Exicure as a shell company. I had hope that we would become some type of business hub focused on renewable energy I mean 30k sq ft isn't bad for starters plus half of that is leased office staff is already and believe it to be a S. Korean entity.
πŸ‘οΈ0
LocWolf LocWolf 5 months ago
Subslover....we are at 55 days of 60 for management to send a plan to the SEC to enable XCUR to remain on the Nasdaq.
πŸ‘οΈ0
glenn1919 glenn1919 5 months ago
XCUR........................................https://stockcharts.com/h-sc/ui?s=XCUR&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
trendzone trendzone 5 months ago
Short manipulators out in force premarket trying to keep their azzas from getting squeezed over a buck, like they were getting in thevafter hours,
πŸ‘οΈ0
adamski adamski 5 months ago
Exicure Granted Broad U.S. Patent #11866700 Today For "Liposomal Nucleic Acid Constructs Presenting Antisense Oligonucleotides For Knockdown Of Interleukin 17 Mrna (For Inflammation From Cancer, Obesity, Diabetes, Alzheimer's)"
πŸ‘οΈ0
subslover subslover 5 months ago
XCUR $1.00?
πŸ‘οΈ0
glenn1919 glenn1919 6 months ago
XCUR.............................https://stockcharts.com/h-sc/ui?s=XCUR&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
LocWolf LocWolf 6 months ago
We might have a market maker buying up all these shares we have seen in the past week or so. I mean you know XCUR is in a real bind about getting delisted to the OTC and the business hope is clear they need a private company to reverse merge but what will we become. Northwestern University is done with us as I see things. Seems Exicure has leased half of their corporate floor area so what is next? I still sense something referencing South Korea...maybe importing exporting???
πŸ‘οΈ0
power11 power11 6 months ago
PURE GARBAGE !! DUMPOOOOOOO
πŸ‘οΈ0
LocWolf LocWolf 6 months ago
It seems someone is taking up house keeping in Exicure.
πŸ‘οΈ0
LocWolf LocWolf 6 months ago
Since we did not hear anything from Exicure yet I would think someone loaned the company money however, if we do have a business deal that might be announced after close tonight I have no doubt we will head in a entirely different direction if that is the case. Is there a private company wishing to go public, that would be our best bet, at least that is how I feel.
πŸ‘οΈ0
subslover subslover 6 months ago
Thanks, Wolf
πŸ‘οΈ0
Invest-in-America Invest-in-America 6 months ago
XCUR: NOTHING out there, Boss. Except this typical "its price is soaring, because its price is soaring" nonsense!! And the following is the SAME website that months ago said that XCUR could some day EXPLODE.
https://investorplace.com/2023/12/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-dec-8th/

PS: I just got out of BED, Homeboy!!! (West Coast sucks for this stuff!!!)
πŸ‘οΈ0
TheFinalCD TheFinalCD 6 months ago
XCUR .64 WHATS THE NEWS??
https://finviz.com/quote.ashx?t=XCUR&ty=c&ta=1&p=d
https://dilutiontracker.com/app/search/XCUR
πŸ‘οΈ0
Invest-in-America Invest-in-America 6 months ago
XCUR: "There's something happening here; what it is ain't exactly clear."

πŸ‘οΈ0
Invest-in-America Invest-in-America 6 months ago
XCUR: Some hints from old news below. (Perhaps a PR tomorrow about a Central Nervous System fix???)
https://investorplace.com/2023/04/3-nano-cap-penny-stocks-to-buy-for-explosive-gains-in-2023/
πŸ‘οΈ0
LocWolf LocWolf 6 months ago
I see that too and tend to believe that Exicure finally has a private entities that will reverse merge with us. No doubt we were prime time, clean and a value just waiting on a player. we will here something as to an 8-K in the next hour or tomorrow sometime.I doubt that was insiders pumping this up but who knows for sure. I company that originally bought us after the reverse split lost their a$$ big time so I don't see another player like that to lose money again. https://www.nasdaq.com/market-activity/stocks/xcur/after-hours
πŸ‘οΈ0
subslover subslover 6 months ago
EXPLODING! On what? I have no clue
πŸ‘οΈ0
Invest-in-America Invest-in-America 6 months ago
XCUR: You all MISSED it!!! (Except me???)
πŸ‘οΈ0
LocWolf LocWolf 6 months ago
Yeap...right on time but a 8-K instead of the late 10-Q.

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001698530/000169853023000123/xcur-20231201.htm
πŸ‘οΈ0
LocWolf LocWolf 6 months ago
XCUR should be coughing up the late 10-Q tonight or Monday morning.
πŸ‘οΈ0
LocWolf LocWolf 6 months ago
Holy Moly grab your socks...payback for that nasty reverse split XCUR. Mess with us shareholders... back at you!
πŸ‘οΈ0
LocWolf LocWolf 6 months ago
I see XCUR went sub .50 cent recently may watch this a bit closer.
πŸ‘οΈ0
LocWolf LocWolf 7 months ago
I appears when you reverse split us shareholders payback a "beach" 😂
πŸ‘οΈ0
LocWolf LocWolf 7 months ago
It looks like they are trying to hold this from dropping any further but don't believe they will be successful and .50 may come into play.

That is what they get for screwing with us shareholders.
πŸ‘οΈ0
LocWolf LocWolf 8 months ago
I'm still looking at the possibilities of 50 cent entry again coupled with delisting threat and RM pressures. The timing will be critical!
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock